Moreover, treatment with a p-Akt inhibitor in a diabetes model aggravates apoptosis, cell survival, and islet β cell dysfunction, and inhibiting Par-4 expression relieves these processes. This evidence concerns the gene AKT1 and diabetes mellitus.